Viewing Study NCT04346992


Ignite Creation Date: 2025-12-24 @ 3:46 PM
Ignite Modification Date: 2025-12-24 @ 3:46 PM
Study NCT ID: NCT04346992
Status: COMPLETED
Last Update Posted: 2022-09-08
First Post: 2020-04-12
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
Sponsor: Fayoum University
Organization:

Study Overview

Official Title: Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
Status: COMPLETED
Status Verified Date: 2022-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease
Detailed Description: Aim of the work

We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD.

Materials and methods

Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:

VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study

Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group

Exclusion criteria Uncooperative patients

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: